Rutgers University-New Brunswick

Two-Thirds of Adults Support Vaccination, National Survey Says

Likelihood to embrace vaccination varies with age, political affiliation, education

Newswise — When a COVID-19 vaccine becomes available, 66 percent of adults are likely to get vaccinated, and have their children vaccinated as well, according to a new nationwide survey led by researchers from Rutgers University–New Brunswick, Northeastern, Harvard, and Northwestern universities. 

The likelihood of who will seek a vaccination differed among states and social groups. Influences on their decision making also varied.

The survey, published by The COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States, indicates that women, African Americans and Republicans are more hesitant about getting a COVID-19 vaccine.

The likelihood of getting vaccinated is below 60 percent in 10 states: Alabama, Arkansas, Louisiana, Mississippi, Missouri, South Dakota, Ohio, Oklahoma, West Virginia and Wyoming. It is greater than 70 percent in 11 other states: Arizona, California, Iowa, Maryland, Massachusetts, Minnesota, North Dakota, New York, Rhode Island, Utah, and Washington, as well as in the District of Columbia. 

The researchers say more outreach efforts will be needed for these groups once a vaccine is available.

“Health experts expect that a COVID-19 vaccine will be ready for the public in the first half of next year,” said co-author Katherine Ognyanova, an assistant professor of communication at Rutgers University–New Brunswick’s School of Communication and Information. “But will the public be ready for a vaccine? We may need to reach 70-90 percent immunity among the population to get the disease fully under control and have herd protection for those vulnerable. 

The survey also found that only 58 percent of those without a high school diploma say they plan to get vaccinated, compared to 78 percent of those with at least a bachelor’s degree. Fifty-nine percent of those who earn less than $25,000 anticipate vaccinating, compared to 78 percent of those who earn more than $100,000.

Young adults (18-24) and older adults (65+) are more likely to say they will likely get vaccinated (71 and 73 percent respectively) than those aged 25-44 and 45-64 (63 and 64 percent). 

Gaps in the likelihood of seeking vaccination are also based on party affiliation: 62 percent of Republicans say they would be likely to seek vaccination, compared to 75 percent of Democrats.

For those who said they are likely to be vaccinated, 62 percent identify the need to protect themselves and their families as a motivation. Forty-five percent cite protecting people in their community and 59 percent identify medical professionals' recommendations as a factor. For those who say they were less likely, 33 percent prioritize protecting themselves and their families and 18 percent protecting the community, with 26 percent identifying a medical professional's recommendation as an important consideration.

“In designing public health strategies to increase vaccine acceptance, the desire to protect others or follow medical advice may not be effective motivations for a majority of those not planning to seek vaccination,” said Ognyanova.

The researchers polled 19,058 people across all 50 states plus the District of Columbia from July 10 to July 26.

The COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States is a joint project of Rutgers University, Northeastern University, Harvard University and Northwestern University. The consortium has released eight reports and has charted public opinion related to covid-19 topics since late April. 

For more information, visit: covidstates.org.




Filters close

Showing results

110 of 3327
Newswise: How to Keep Children Safe from COVID-19 this Fall
Released: 18-Sep-2020 4:15 PM EDT
How to Keep Children Safe from COVID-19 this Fall
Rush University Medical Center

With the new school year started and autumn approaching, Colleen Nash, MD, MPH, Rush University Medical Center, pediatric infectious disease specialist, answers questions parents may have about keeping children safe from COVID, social distancing in the classroom and celebrating Halloween.

Released: 18-Sep-2020 4:05 PM EDT
Claims circulating on social media stating that the common cold or flu can be mistaken for COVID-19 are misleading
Newswise

The claims rely on the faulty assumption that there is no method to distinguish COVID-19 from the common cold and the flu.

Released: 18-Sep-2020 3:35 PM EDT
After developing CRISPR test, UConn researchers validate clinical feasibility for COVID-19 testing
University of Connecticut

In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2).

Newswise:Video Embedded blowin-in-the-wind
VIDEO
Released: 18-Sep-2020 3:10 PM EDT
Blowin' in the wind
University of Utah

University of Utah chemical engineers have conducted an air flow study of the venue that the Utah Symphony performs in to determine the best ways to mitigate the spread of COVID-19 through the emissions of wind instrument players.

Newswise: holman1_toned-1-768x512.jpg
Released: 18-Sep-2020 2:50 PM EDT
Study links rising stress, depression in U.S. to pandemic-related losses, media consumption
University of California, Irvine

Irvine, Calif., Sept. 18, 2020 – Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study. The report appears in Science Advances, published by the American Association for the Advancement of Science.

Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.


Showing results

110 of 3327

close
1.24359